• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴细胞归巢受体的表达作为非霍奇金淋巴瘤播散的一种机制。

Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma.

作者信息

Pals S T, Horst E, Ossekoppele G J, Figdor C G, Scheper R J, Meijer C J

机构信息

Department of Pathology, Free University, Amsterdam, The Netherlands.

出版信息

Blood. 1989 Mar;73(4):885-8.

PMID:2645948
Abstract

To investigate whether the lymphocyte homing receptor (LHR), an adhesion molecule believed to play an important role in the control of normal lymphocyte circulation, influences the spread of non-Hodgkin's lymphoma (NHL), expression of LHR was examined in 107 NHL of various histologic and immunophenotypic subclasses. This analysis revealed that whereas NHL with a putative derivation from recirculating mature T and B lymphocytes almost invariably express high levels of LHR, those akin to sessile mature or immature lymphocytes tend to express lower levels of LHR. Furthermore, in a survey among diffuse large-cell lymphomas of the B-lineage, the tumors of 11 of 13 patients with stage III/IV disease expressed moderate to high levels of LHR, whereas only two of 17 patients with stage I/II disease had tumors that did so. These findings suggest that LHR is involved in the dissemination of NHL.

摘要

为了研究淋巴细胞归巢受体(LHR),一种被认为在正常淋巴细胞循环控制中起重要作用的黏附分子,是否影响非霍奇金淋巴瘤(NHL)的扩散,我们检测了107例不同组织学和免疫表型亚类的NHL中LHR的表达。该分析显示,推测源自再循环成熟T和B淋巴细胞的NHL几乎总是表达高水平的LHR,而那些类似于固定成熟或未成熟淋巴细胞的NHL倾向于表达较低水平的LHR。此外,在一项对B细胞系弥漫性大细胞淋巴瘤的调查中,13例III/IV期疾病患者中有11例的肿瘤表达中度至高水平的LHR,而17例I/II期疾病患者中只有2例的肿瘤是如此。这些发现表明LHR参与了NHL的扩散。

相似文献

1
Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma.淋巴细胞归巢受体的表达作为非霍奇金淋巴瘤播散的一种机制。
Blood. 1989 Mar;73(4):885-8.
2
Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma.淋巴细胞归巢受体抗原在非霍奇金淋巴瘤中的表达
Am J Pathol. 1988 Mar;130(3):496-504.
3
Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54).黏附分子在弥漫性大细胞淋巴瘤预后中的作用:淋巴细胞归巢受体(CD44)、淋巴细胞功能相关抗原-1(LFA-1,CD11a/18)和细胞间黏附分子-1(ICAM-1,CD54)的表达
Leukemia. 1990 Aug;4(8):595-9.
4
Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development.人归巢受体(CD44)在淋巴系统恶性肿瘤及淋巴发育相关阶段中的表达。
Leukemia. 1990 May;4(5):383-9.
5
Expression of the human peripheral lymph node homing receptor (LECAM-1) in nodal and gastrointestinal non-Hodgkin's lymphomas.人外周淋巴结归巢受体(LECAM-1)在淋巴结及胃肠道非霍奇金淋巴瘤中的表达
Leukemia. 1991 Jul;5(7):628-31.
6
Adhesion molecules in the dissemination of non-Hodgkin's lymphomas.黏附分子在非霍奇金淋巴瘤播散中的作用
Acta Haematol. 1997;97(1-2):73-80. doi: 10.1159/000203662.
7
Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.黏膜归巢受体整合素α4β7在胃肠道非霍奇金淋巴瘤中的优先表达。
Am J Pathol. 1997 Mar;150(3):919-27.
8
Immunologic markers in non-Hodgkin's lymphoma.非霍奇金淋巴瘤中的免疫标志物
Hematol Oncol Clin North Am. 1991 Oct;5(5):871-89.
9
CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).B细胞非霍奇金淋巴瘤(NHL)或霍奇金病(HD)侵袭的肿瘤中CD4 T淋巴细胞的CD45RA表达。
Am J Hematol. 1992 Jan;39(1):45-51. doi: 10.1002/ajh.2830390110.
10
Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma.淋巴细胞归巢受体和S期分数在非霍奇金淋巴瘤中的预后价值
Blood. 1990 Apr 1;75(7):1549-56.

引用本文的文献

1
Anti-Proliferation Effect of Theasaponin E₁ on the ALDH-Positive Ovarian Cancer Stem-Like Cells.表没食子儿茶素没食子酸酯(Theasaponin E₁)对 ALDH 阳性卵巢癌干细胞的抗增殖作用。
Molecules. 2018 Jun 17;23(6):1469. doi: 10.3390/molecules23061469.
2
Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.CD44 在霍奇金淋巴瘤和非霍奇金淋巴瘤中的表观遗传调控。
BMC Cancer. 2010 Sep 29;10:517. doi: 10.1186/1471-2407-10-517.
3
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.
基质金属蛋白酶9定位于细胞表面为CD44介导的肿瘤侵袭提供了一种机制。
Genes Dev. 1999 Jan 1;13(1):35-48. doi: 10.1101/gad.13.1.35.
4
Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.CD44变异体同工型6和4/5在乳腺癌中的表达。与既定预后参数的相关性。
Arch Gynecol Obstet. 1996;258(3):125-35. doi: 10.1007/s004040050113.
5
Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity.在MDAY-D2淋巴肉瘤细胞中对CD44进行靶向破坏,对皮下生长或转移能力没有影响。
J Cell Biol. 1995 Dec;131(6 Pt 2):1849-55. doi: 10.1083/jcb.131.6.1849.
6
Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.活化的人类淋巴细胞和侵袭性非霍奇金淋巴瘤表达一种大鼠转移相关的CD44变体的同源物。
J Exp Med. 1993 Apr 1;177(4):897-904. doi: 10.1084/jem.177.4.897.
7
Glycoprotein CD44 expression and its association with survival in breast cancer.糖蛋白CD44表达及其与乳腺癌生存的关系。
Am J Pathol. 1993 Sep;143(3):867-74.
8
Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.淋巴细胞归巢受体(CD44)的表达与胃肠道淋巴瘤的不良预后相关。
Br J Cancer. 1993 Aug;68(2):428-32. doi: 10.1038/bjc.1993.354.
9
Expression of an adhesion molecule and homing in B-cell chronic lymphocytic leukaemia: I. Application of the HEV-binding assay to a clinical series.
Med Oncol Tumor Pharmacother. 1993;10(3):125-30. doi: 10.1007/BF02987779.
10
Expression of an adhesion molecule and homing in B-cell chronic lymphocytic leukaemia: II. L-selectin expression mediated cell adhesion revealed by immobilized analogue carbohydrates in B-cell chronic lymphocytic leukaemia and monoclonal lymphocytosis of undetermined significance.黏附分子的表达与B细胞慢性淋巴细胞白血病中的归巢:II. 固定化类似碳水化合物揭示L-选择素表达介导的细胞黏附在B细胞慢性淋巴细胞白血病和意义未明的单克隆淋巴细胞增多症中的情况
Med Oncol Tumor Pharmacother. 1993;10(4):173-80. doi: 10.1007/BF02989666.